Blood Cancer drug side effects need new monitoring

The Lancet Haematology: Modern blood cancer treatments require new approaches for monitoring and reporting side effects of drugs Treatment changes including the advent of targeted and immune therapies have dramatically improved survival for blood cancers, but new report calls for improved evaluation of poorly understood side effects that may develop over time. Survival rates for … Continue reading Blood Cancer drug side effects need new monitoring